1. by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal
Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma
by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal
Blood
Volume 132(8):
August 23, 2018
©2018 by American Society of Hematology

2. Victor A. Chow et al. Blood 2018;132:777-781
©2018 by American Society of Hematology

3. Proposed schema for use of anti-CD19 CAR T-cell therapy in clinical practice.
Proposed schema for use of anti-CD19 CAR T-cell therapy in clinical practice. PR, partial response; Rx, treatment. *Proceed to salvage 2 or CAR T-cell therapy. †Proceed to salvage 2, CAR T-cell therapy, or ASCT. ‡Proceed to CAR T-cell therapy ± salvage 3.
Victor A. Chow et al. Blood 2018;132:
©2018 by American Society of Hematology